(Q35150877)

6 August 2017

1 reference

title

Control of angiogenesis by heparin and other sulfated polysaccharides (English)

1 reference

6 August 2017

Control of Angiogenesis by Heparin and Other Sulfated Polysaccharides (English)

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

20 November 2023

1 reference

1 reference

1 reference

1

J Folkman

1 reference

6 August 2017

Y. Shing

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1279952

8 September 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

full work available at URL

6 August 2017

http://link.springer.com/content/pdf/10.1007/978-1-4899-2444-5_34

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Advances in Experimental Medicine and Biology

20 November 2023

published in

1 reference

6 August 2017

313

1 reference

6 August 2017

355-364

1 reference

Mast cell heparin stimulates migration of capillary endothelial cells in vitro

6 August 2017

1

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Binding and endocytosis of heparin by human endothelial cells in culture

20 November 2023

2

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Syndecan, a developmentally regulated cell surface proteoglycan that binds extracellular matrix and growth factors

20 November 2023

3

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Basic fibroblast growth factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing G0----G1 transition

20 November 2023

4

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Bovine retina contains three growth factor activities with different affinity to heparin: eye derived growth factor I, II, III.

20 November 2023

7

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment

20 November 2023

8

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF.

20 November 2023

10

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

A unique heparan sulfate in the nuclei of hepatocytes: structural changes with the growth state of the cells.

20 November 2023

12

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells

20 November 2023

13

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

20 November 2023

Angiogenic factors

15

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Angiostatic steroids. Method of discovery and mechanism of action

20 November 2023

16

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

What Is the Evidence That Tumors Are Angiogenesis Dependent?

20 November 2023

22

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing

20 November 2023

24

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Release of endothelial cell-derived growth factor (ECDGF) by heparin

20 November 2023

25

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Heparin protects basic and acidic FGF from inactivation

20 November 2023

27

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

The sulfated polysaccharide-peptidoglycan complex potently inhibits embryonic angiogenesis and tumor growth in the presence of cortisone acetate

20 November 2023

29

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

A simple method for shell-less cultivation of chick embryos

20 November 2023

30

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Mast cells and tumor angiogenesis

20 November 2023

31

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Heparin affinity of anionic and cationic capillary endothelial cell growth factors: analysis of hypothalamus-derived growth factors and fibroblast growth factors

20 November 2023

32

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Oral heparin results in the appearance of heparin fragments in the plasma of rats

20 November 2023

34

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain.

20 November 2023

37

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides

20 November 2023

38

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Journal of Pharmacology and Experimental Therapeutics

20 November 2023

40

251

679

ME Maragoudakis

1989

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Mr 25,000 heparin-binding protein from guinea pig brain is a high molecular weight form of basic fibroblast growth factor

20 November 2023

41

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan

20 November 2023

43

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

On mast-cell-mediated angiogenesis in the rat mesenteric-window assay

20 November 2023

44

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Treatment of haemangioendotheliomas with alpha interferon

20 November 2023

45

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

20 November 2023

Journal of Cell Biology

46

109

311a

T Pereles

1989

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitro

20 November 2023

47

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

20 November 2023

Invasion and metastasis

50

7

208

N Sakamoto

1987

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation

20 November 2023

52

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Interaction of endothelial cell growth factor with heparin: characterization by receptor and antibody recognition

20 November 2023

53

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth Factor

20 November 2023

54

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Affinity of fibroblast growth factors for beta-cyclodextrin tetradecasulfate

20 November 2023

55

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

The Combination of a Bacterial Polysaccharide and Tamoxifen Inhibits Angiogenesis and Tumour Growth

20 November 2023

60

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Protamine is an inhibitor of angiogenesis

20 November 2023

61

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Purification and characterization of acidic fibroblast growth factor from bovine brain

20 November 2023

62

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Heparin-mediated release of fibroblast growth factor-like activity into the circulation of rabbits

20 November 2023

63

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Human endothelial cells: use of heparin in cloning and long-term serial cultivation

20 November 2023

64

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Internalization and metabolism of endogenous heparin by cultured endothelial cells

20 November 2023

65

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix

20 November 2023

66

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis

20 November 2023

67

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

20 November 2023

68

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a

20 November 2023

69

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Inhibition of angiogenesis with combination treatments of angiostatic steroids and suramin

20 November 2023

70

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

20 November 2023

71

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_34

20 November 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1279952

8 September 2022

1 reference